Intraarticular hyaluronic acid injections enye yeendlela zokonyango ze- knee osteoarthritis . Yintoni esiyayaziyo malunga nokusebenza kwe-hyaluronic acid kwi-hip? Ngaba i-hyaluronic acid injections ifunyenwe ngamanye amanxeba okanye ingasetyenziswa ngokuyinhloko ukuphatha i-knee osteoarthritis?
I-Hyaluronic Acid Injections Ngaba i-FDA-Iyavunyelwa ukuba i-Knee Osteoarthritis kodwa ingabi nge-Hips
I-Hyaluronic acid injections ziye zavunyelwa i-FDA iminyaka emininzi njengonyango lwe-knee osteoarthritis.
Kodwa i-hyaluronic acid ayizange ivunyiwe ngenxa yeenyawo okanye ezinye izihlanganisi. Nangona kunjalo, abanye oogqirha baye basebenzisa i-label-label for injection of hip kwizigulane zabo. Ngokomzekelo, i-Blue Cross / Blue Shield ye-inshurensi yezobugqirha ibona injini-articular injections kuyo nayiphi na ingxube ngaphandle kwamadolo ukuba uphando kodwa kungekho mfuneko yonyango. Abaphandi baye bafunda ukuphumelela kwe-injection ye-hyaluronic acid ye-hip kwaye iziphumo zazingekho kakuhle. I-American College yeRheumatology ayinakuyincoma ukuyisebenzisa kwi-hip osteoarthritis.
Injectable Hyaluronic Acid Drugs
Kukho imveliso emininzi ye-hyaluronic acid, kunye ne- synvisc eyona yavunywa kuqala. Euflexxa, Orthovisc , Hyalgan, kunye noSupartz ngabanye. I-Synvisc-One yavunywa ngoFebruwari 26, 2009, njengokwenziwa kwe-injection eyodwa ye-Synvisc, efuna uchungechunge lweejectors ezintathu.
- Yintoni iViscosupplementation? Funda malunga nendlela ezi zisetyenziselwa ngayo i-knee osteoarthritis.
- I-Hyaluronan Injections ye-Knee Osteoarthritis : izinto ezili-10 omele wazi ngazo ngale nyango.
- Izibilini Zobunjineli Ezihlangeneyo : Ingxoxo engakumbi malunga nezifundo zandul 'ukuba ziphumelele kwi-knee osteoarthritis.
I-Hyaluronic Acid ayifanelekanga kwi-Hip Osteoarthritis
I-Hyaluronic acid ijolise ukubuyisela izakhiwo eziqhelekileyo ze-synovial fluid.
Kuye kwacetyiswa ukuba i-hyaluronic acid ingaba nefuthe ekukhuseleni kwi- cartilage , kwaye inganciphisa umveliso kunye nomsebenzi weekhemikhali ezibandakanyekayo ekuvukeleni (njengabalamli be-proinflammatory, metalloproteinases yamatriki).
Ngokomnye uphando, i-injection esisodwa ye-hyaluronic acid ayiyisebenzisi i- hip osteoarthritis- eneneni, ayikho into ephumelelayo kune-placebo. Ngenxa yokuba i-hyaluronic acid isuswa ngokukhawuleza kumalungu, i-injection engaphezu kweyodwa inokufuneka ukuba inikwe inzuzo. Ukususwa ngokukhawuleza kwe-acaluronic acid yinto enye yeso sizathu sokuba kutheni ama-injections amaninzi avelise umphumo ongcono.
Izifundo ezazijonge ukusebenza kwe-hyaluronic acid kwi-hip osteoarthritis ziye zincinci kwaye zincinci. Kufuneka uphando olongezelelweyo ukuchonga ukuba i-hyaluronic acid iyindlela efanelekileyo yokunyangwa kwamalungu angaphandle kwegolo.
I-Hyaluronic Acid Injections kwaye ilahlekelwe nguKnee Osteoarthritis
Ukuhlaziywa kweCchrane kwezifundo ezingama-76, ezanyatheliswa ngo-2006, zagqitywa ukuba i-hyaluronic acid yayingasasebenzi ngokubanzi kwi-knee osteoarthritis kune-NSAID. Yanciphisa amanqanaba entlungu, kodwa ayikho ngaphaya kwelo hlobo lonyango, kwaye ithatha iiveki ezintlanu ukuvelisa iziphumo ezipheleleyo. Inzuzo yayikukuba imiphumo ingahlala ihlala ixesha elide.
Ngokusekelwe ekuphononongweni kwezifundo ezili-15, i-American Academy ye-Orthopedic Surgeons (AAOS) ikhuphe iingcebiso ezintsha ngo-Juni 2013 ngokuthi i-hyaluronic acid ayihlangabezi ubuncinane beendlela zokuphucula ezibalulekileyo kwiklinikhi. Oku kunokukhokelela oogqirha abancinci nabancinci basebenzisa ii-injection kwi-knee osteoarthritis.
Imithombo:
Umphumo we-hyaluronic acid kwi-hip osteoarthritis yesifo: I-trial ye-multipleboats, i-randomized, i-placebo elawulwa yi-placebo. Arthritis & Rheumatism. Matshi 2009. Richette P et al.
I-Hyaluronic Acid Injections ye-Osteoarthritis, uTimoti Gower, i-Arthritis Foundation, ifike ngomhla we-1/5/16.
Bellamy N, et. al. "Ukuhlaziywa kwenkqubo yokunyanga kwe-osteoarthritis yamadolo." Cochrane, 19 uEpreli 2006.
Hochberg MC, Altman RD, uEpreli KT, et al. Iikholeji zaseMelika zeRheumatology 2012 iingcebiso malunga nokusetyenziswa kwezinto ezingenantopharmacologic kunye ne-pharmacologic therapies kwi-osteoarthritis yesandla, i-hip, namadolo. I-Arthritis Care Res (i-Hoboken). 2012; 64 (4): 465-474.
Unyango lwe-Osteoarthritis ye-Knee-Based Based Guideline 2 Edition. I-American Academy ye-Orthopedic Board of Directors ngoMeyi 18, 2013.